<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32051235</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1098-5557</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>84</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>May</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Microbiology and molecular biology reviews : MMBR</Title>
          <ISOAbbreviation>Microbiol Mol Biol Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Francisella tularensis Polysaccharides: What Is the Real Capsule?</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e00065-19</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/MMBR.00065-19</ELocationID>
        <Abstract>
          <AbstractText><i>Francisella tularensis</i> is a tier 1 select agent responsible for tularemia in humans and a wide variety of animal species. Extensive research into understanding the virulence factors of the bacterium has been ongoing to develop an efficacious vaccine. At least two such virulence factors are described as capsules of <i>F. tularensis</i>: the O-antigen capsule and the capsule-like complex (CLC). These two separate entities aid in avoiding host immune defenses but have not been clearly differentiated. These components are distinct and differ in composition and genetic basis. The O-antigen capsule consists of a polysaccharide nearly identical to the lipopolysaccharide (LPS) O antigen, whereas the CLC is a heterogeneous complex of glycoproteins, proteins, and possibly outer membrane vesicles and tubes (OMV/Ts). In this review, the current understanding of these two capsules is summarized, and the historical references to "capsules" of <i>F. tularensis</i> are clarified. A significant amount of research has been invested into the composition of each capsule and the genes involved in synthesis of the polysaccharide portion of each capsule. Areas of future research include further exploration into the molecular regulation and pathways responsible for expression of each capsule and further elucidating the role that each capsule plays in virulence.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American Society for Microbiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Freudenberger Catanzaro</LastName>
            <ForeName>Kelly C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Inzana</LastName>
            <ForeName>Thomas J</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA Thomas.Inzana@liu.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Long Island University, Brookville, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Microbiol Mol Biol Rev</MedlineTA>
        <NlmUniqueID>9706653</NlmUniqueID>
        <ISSNLinking>1092-2172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011135">Polysaccharides, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016667" MajorTopicYN="N">Bacterial Capsules</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005604" MajorTopicYN="N">Francisella tularensis</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011135" MajorTopicYN="N">Polysaccharides, Bacterial</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014406" MajorTopicYN="N">Tularemia</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">O-antigen capsule</Keyword>
        <Keyword MajorTopicYN="Y">capsule</Keyword>
        <Keyword MajorTopicYN="Y">capsule-like complex</Keyword>
        <Keyword MajorTopicYN="Y">lipopolysaccharide</Keyword>
        <Keyword MajorTopicYN="Y">virulence</Keyword>
        <Keyword MajorTopicYN="Y">virulence factors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32051235</ArticleId>
        <ArticleId IdType="pmc">PMC7018499</ArticleId>
        <ArticleId IdType="doi">10.1128/MMBR.00065-19</ArticleId>
        <ArticleId IdType="pii">84/1/e00065-19</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sjostedt A.
2005. 
Family III. Francisellaceae, p 199–209. In
Brenner DJ, Krieg NR, Garrity GM, Staley JT (ed), Bergey’s manual of systematic bacteriology, 2nd ed, vol 2
Springer, New York, NY.</Citation>
        </Reference>
        <Reference>
          <Citation>Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense. 2001. 
Tularemia as a biological weapon: medical and public health management. JAMA
285:2763–2773. doi:10.1001/jama.285.21.2763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.285.21.2763</ArticleId>
            <ArticleId IdType="pubmed">11386933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. 2005. 
Brief report: tularemia associated with a hamster bite–Colorado, 2004. MMWR Morb Mortal Wkly Rep
53:1202–1203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15635290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francis E.
1925. 
Tularemia. JAMA
84:1243–1250. doi:10.1001/jama.1925.02660430001001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.1925.02660430001001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kugeler KJ, Gurfield N, Creek JG, Mahoney KS, Versage JL, Petersen JM. 
2005. 
Discrimination between Francisella tularensis and Francisella-like endosymbionts when screening ticks by PCR. Appl Environ Microbiol
71:7594–7597. doi:10.1128/AEM.71.11.7594-7597.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.71.11.7594-7597.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1287647</ArticleId>
            <ArticleId IdType="pubmed">16269811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandya GA, Holmes MH, Petersen JM, Pradhan S, Karamycheva SA, Wolcott MJ, Molins C, Jones M, Schriefer ME, Fleischmann RD, Peterson SN. 
2009. 
Whole genome single nucleotide polymorphism based phylogeny of Francisella tularensis and its application to the development of a strain typing assay. BMC Microbiol
9:213. doi:10.1186/1471-2180-9-213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-9-213</ArticleId>
            <ArticleId IdType="pmc">PMC2767358</ArticleId>
            <ArticleId IdType="pubmed">19811647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kingry LC, Petersen JM. 
2014. 
Comparative review of Francisella tularensis and Francisella novicida. Front Cell Infect Microbiol
4:35. doi:10.3389/fcimb.2014.00035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2014.00035</ArticleId>
            <ArticleId IdType="pmc">PMC3952080</ArticleId>
            <ArticleId IdType="pubmed">24660164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molins CR, Delorey MJ, Yockey BM, Young JW, Belisle JT, Schriefer ME, Petersen JM. 
2014. 
Virulence difference between the prototypic Schu S4 strain (A1a) and Francisella tularensis A1a, A1b, A2 and type B strains in a murine model of infection. BMC Infect Dis
14:67. doi:10.1186/1471-2334-14-67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-14-67</ArticleId>
            <ArticleId IdType="pmc">PMC3923427</ArticleId>
            <ArticleId IdType="pubmed">24502661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molins CR, Delorey MJ, Yockey BM, Young JW, Sheldon SW, Reese SM, Schriefer ME, Petersen JM. 
2010. 
Virulence differences among Francisella tularensis subsp. tularensis clades in mice. PLoS One
5:e10205. doi:10.1371/journal.pone.0010205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010205</ArticleId>
            <ArticleId IdType="pmc">PMC2855709</ArticleId>
            <ArticleId IdType="pubmed">20419133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kugeler KJ, Mead PS, Janusz AM, Staples JE, Kubota KA, Chalcraft LG, Petersen JM. 
2009. 
Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis
48:863–870. doi:10.1086/597261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/597261</ArticleId>
            <ArticleId IdType="pubmed">19245342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keim P, Johansson A, Wagner DM. 
2007. 
Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci
1105:30–66. doi:10.1196/annals.1409.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1409.011</ArticleId>
            <ArticleId IdType="pubmed">17435120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention, Department of Health and Human Services. 2017. 
Possession, use, and transfer of select agents and toxins; biennial review of the list of select agents and toxins and enhanced biosafety requirements. Final rule. Fed Regist
82:6278–6294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28106357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oyston PC, Sjostedt A, Titball RW. 
2004. 
Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol
2:967–978. doi:10.1038/nrmicro1045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro1045</ArticleId>
            <ArticleId IdType="pubmed">15550942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLendon MK, Apicella MA, Allen LA. 
2006. 
Francisella tularensis: taxonomy, genetics, and immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol
60:167–185. doi:10.1146/annurev.micro.60.080805.142126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.micro.60.080805.142126</ArticleId>
            <ArticleId IdType="pmc">PMC1945232</ArticleId>
            <ArticleId IdType="pubmed">16704343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartley G, Taylor R, Prior J, Newstead S, Hitchen PG, Morris HR, Dell A, Titball RW. 
2006. 
Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Vaccine
24:989–996. doi:10.1016/j.vaccine.2005.08.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2005.08.075</ArticleId>
            <ArticleId IdType="pubmed">16257097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia Q, Horwitz MA. 
2018. 
Live attenuated tularemia vaccines for protection against respiratory challenge with virulent F. tularensis subsp. tularensis. Front Cell Infect Microbiol
8:154. doi:10.3389/fcimb.2018.00154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2018.00154</ArticleId>
            <ArticleId IdType="pmc">PMC5963219</ArticleId>
            <ArticleId IdType="pubmed">29868510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, Roberts MJ, Ludu JS, Letendre GW, Meierovics AI, Stephens G, Elkins KL. 
2004. 
A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol
186:6430–6436. doi:10.1128/JB.186.19.6430-6436.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.186.19.6430-6436.2004</ArticleId>
            <ArticleId IdType="pmc">PMC516616</ArticleId>
            <ArticleId IdType="pubmed">15375123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santic M, Molmeret M, Barker JR, Klose KE, Dekanic A, Doric M, Abu Kwaik Y. 
2007. 
A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol. Cell Microbiol
9:2391–2403. doi:10.1111/j.1462-5822.2007.00968.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2007.00968.x</ArticleId>
            <ArticleId IdType="pubmed">17517064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nano FE, Schmerk C. 
2007. 
The Francisella pathogenicity island. Ann N Y Acad Sci
1105:122–137. doi:10.1196/annals.1409.000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1409.000</ArticleId>
            <ArticleId IdType="pubmed">17395722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradov E, Perry MB, Conlan JW. 
2002. 
Structural analysis of Francisella tularensis lipopolysaccharide. Eur J Biochem
269:6112–6118. doi:10.1046/j.1432-1033.2002.03321.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1432-1033.2002.03321.x</ArticleId>
            <ArticleId IdType="pubmed">12473106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ. 
2007. 
Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology
153:3141–3153. doi:10.1099/mic.0.2007/006460-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.2007/006460-0</ArticleId>
            <ArticleId IdType="pubmed">17768257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clay CD, Soni S, Gunn JS, Schlesinger LS. 
2008. 
Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol
181:5568–5578. doi:10.4049/jimmunol.181.8.5568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.8.5568</ArticleId>
            <ArticleId IdType="pmc">PMC2782685</ArticleId>
            <ArticleId IdType="pubmed">18832715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apicella MA, Post DM, Fowler AC, Jones BD, Rasmussen JA, Hunt JR, Imagawa S, Choudhury B, Inzana TJ, Maier TM, Frank DW, Zahrt TC, Chaloner K, Jennings MP, McLendon MK, Gibson BW. 
2010. 
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One
5:e11060. doi:10.1371/journal.pone.0011060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0011060</ArticleId>
            <ArticleId IdType="pmc">PMC2897883</ArticleId>
            <ArticleId IdType="pubmed">20625403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandara AB, Champion AE, Wang X, Berg G, Apicella MA, McLendon M, Azadi P, Snyder DS, Inzana TJ. 
2011. 
Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. PLoS One
6:e19003. doi:10.1371/journal.pone.0019003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0019003</ArticleId>
            <ArticleId IdType="pmc">PMC3081320</ArticleId>
            <ArticleId IdType="pubmed">21544194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherwonogrodzky JW, Knodel MH, Spence MR. 
1994. 
Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium. Vaccine
12:773–775. doi:10.1016/0264-410x(94)90284-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0264-410x(94)90284-4</ArticleId>
            <ArticleId IdType="pubmed">7975855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadevall A, Pirofski LA. 
2009. 
Virulence factors and their mechanisms of action: the view from a damage-response framework. J Water Health
7(Suppl 1):S2–S18. doi:10.2166/wh.2009.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2166/wh.2009.036</ArticleId>
            <ArticleId IdType="pubmed">19717929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monick MM, Powers LS, Hassan I, Groskreutz D, Yarovinsky TO, Barrett CW, Castilow EM, Tifrea D, Varga SM, Hunninghake GW. 
2007. 
Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J Immunol
179:1648–1658. doi:10.4049/jimmunol.179.3.1648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.179.3.1648</ArticleId>
            <ArticleId IdType="pmc">PMC4060898</ArticleId>
            <ArticleId IdType="pubmed">17641031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Riordan K, Lee JC. 
2004. 
Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev
17:218–234. doi:10.1128/cmr.17.1.218-234.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/cmr.17.1.218-234.2004</ArticleId>
            <ArticleId IdType="pmc">PMC321462</ArticleId>
            <ArticleId IdType="pubmed">14726462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitfield C.
1988. 
Bacterial extracellular polysaccharides. Can J Microbiol
34:415–420. doi:10.1139/m88-073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1139/m88-073</ArticleId>
            <ArticleId IdType="pubmed">3052752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezzell JW, Welkos SL. 
1999. 
The capsule of Bacillus anthracis, a review. J Appl Microbiol
87:250. doi:10.1046/j.1365-2672.1999.00881.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2672.1999.00881.x</ArticleId>
            <ArticleId IdType="pubmed">10475959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews GP, Heath DG, Anderson GW Jr, Welkos SL, Friedlander AM. 
1996. 
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun
64:2180–2187. doi:10.1128/IAI.64.6.2180-2187.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.64.6.2180-2187.1996</ArticleId>
            <ArticleId IdType="pmc">PMC174053</ArticleId>
            <ArticleId IdType="pubmed">8675324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCoy GW.
1910. 
Plague among ground squirrels in America. J Hyg (Lond)
10:589–601. doi:10.1017/s002217240004314x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/s002217240004314x</ArticleId>
            <ArticleId IdType="pmc">PMC2167323</ArticleId>
            <ArticleId IdType="pubmed">20474433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlisle HN, Hinchliffe V, Saslaw S. 
1962. 
Immunodiffusion studies with Pasteurella tularensis antigen-rabbit antibody systems. J Immunol
89:638–644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14018678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hood AM.
1977. 
Virulence factors of Francisella tularensis. J Hyg (Lond)
79:47–60. doi:10.1017/s0022172400052840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/s0022172400052840</ArticleId>
            <ArticleId IdType="pmc">PMC2129918</ArticleId>
            <ArticleId IdType="pubmed">267668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tigertt WD.
1962. 
Soviet viable Pasteurella tularensis vaccines. A review of selected articles. Bacteriol Rev
26:354–373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC441156</ArticleId>
            <ArticleId IdType="pubmed">13985026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eigelsbach HT, Braun W, Herring RD. 
1951. 
Studies on the variation of Bacterium tularense. J Bacteriol
61:557–569. doi:10.1128/JB.61.5.557-569.1951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.61.5.557-569.1951</ArticleId>
            <ArticleId IdType="pmc">PMC386045</ArticleId>
            <ArticleId IdType="pubmed">14832199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandström G, Löfgren S, Tärnvik A. 
1988. 
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun
56:1194–1202. doi:10.1128/IAI.56.5.1194-1202.1988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.56.5.1194-1202.1988</ArticleId>
            <ArticleId IdType="pmc">PMC259783</ArticleId>
            <ArticleId IdType="pubmed">3356465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eigelsbach HT, Downs CM. 
1961. 
Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol
87:415–425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13889609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowley SC, Myltseva SV, Nano FE. 
1996. 
Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol
20:867–874. doi:10.1111/j.1365-2958.1996.tb02524.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.1996.tb02524.x</ArticleId>
            <ArticleId IdType="pubmed">8793882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Titball R, Petrosino J. 
2007. 
Francisella tularensis genomics and proteomics. Ann N Y Acad Sci
1105:98–121. doi:10.1196/annals.1409.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1409.015</ArticleId>
            <ArticleId IdType="pubmed">17435122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorokin VM, Pavlovich NV, Prozorova LA. 
1996. 
Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol Med Microbiol
13:249–252. doi:10.1111/j.1574-695X.1996.tb00246.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-695X.1996.tb00246.x</ArticleId>
            <ArticleId IdType="pubmed">8861038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker JH, Kaufman JW, Apicella MA, Weiss JP. 
2016. 
Evidence suggesting that Francisella tularensis O-antigen capsule contains a lipid A-like molecule that is structurally distinct from the more abundant free lipid A. PLoS One
11:e0157842. doi:10.1371/journal.pone.0157842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0157842</ArticleId>
            <ArticleId IdType="pmc">PMC4915664</ArticleId>
            <ArticleId IdType="pubmed">27326857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen JA, Fletcher JR, Long ME, Allen LA, Jones BD. 
2015. 
Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies. Front Microbiol
6:338. doi:10.3389/fmicb.2015.00338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2015.00338</ArticleId>
            <ArticleId IdType="pmc">PMC4419852</ArticleId>
            <ArticleId IdType="pubmed">25999917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen JA, Post DM, Gibson BW, Lindemann SR, Apicella MA, Meyerholz DK, Jones BD. 
2014. 
Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia. Infect Immun
82:1523–1539. doi:10.1128/IAI.01640-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01640-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993386</ArticleId>
            <ArticleId IdType="pubmed">24452684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen LA, Jones BD. 
2011. 
Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect Immun
79:581–594. doi:10.1128/IAI.00863-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00863-10</ArticleId>
            <ArticleId IdType="pmc">PMC3028865</ArticleId>
            <ArticleId IdType="pubmed">21078861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLendon MK, Schilling B, Hunt JR, Apicella MA, Gibson BW. 
2007. 
Identification of LpxL, a late acyltransferase of Francisella tularensis. Infect Immun
75:5518–5531. doi:10.1128/IAI.01288-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01288-06</ArticleId>
            <ArticleId IdType="pmc">PMC2168286</ArticleId>
            <ArticleId IdType="pubmed">17724076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL. 
2007. 
A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun
75:2591–2602. doi:10.1128/IAI.01789-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01789-06</ArticleId>
            <ArticleId IdType="pmc">PMC1865767</ArticleId>
            <ArticleId IdType="pubmed">17296751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twine SM, Vinogradov E, Lindgren H, Sjostedt A, Conlan JW. 
2012. 
Roles for wbtC, wbtI, and kdtA genes in lipopolysaccharide biosynthesis, protein glycosylation, virulence, and immunogenicity in Francisella tularensis strain SCHU S4. Pathogens
1:12–29. doi:10.3390/pathogens1010012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pathogens1010012</ArticleId>
            <ArticleId IdType="pmc">PMC4141488</ArticleId>
            <ArticleId IdType="pubmed">25152813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twine SM, Mykytczuk NC, Petit MD, Shen H, Sjostedt A, Wayne Conlan J, Kelly JF. 
2006. 
In vivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen. Biochem Biophys Res Commun
345:1621–1633. doi:10.1016/j.bbrc.2006.05.070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2006.05.070</ArticleId>
            <ArticleId IdType="pubmed">16730660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hazlett KR, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS, Magguilli ML, Malik M, Shah A, Broderick S, Golovliov I, Metzger DW, Rajan K, Sellati TJ, Loegering DJ. 
2008. 
Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect Immun
76:4479–4488. doi:10.1128/IAI.00610-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00610-08</ArticleId>
            <ArticleId IdType="pmc">PMC2546835</ArticleId>
            <ArticleId IdType="pubmed">18644878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, Gosselin EJ, Sellati TJ, Hazlett KR. 
2011. 
Host-adaptation of Francisella tularensis alters the bacterium’s surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One
6:e22335. doi:10.1371/journal.pone.0022335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0022335</ArticleId>
            <ArticleId IdType="pmc">PMC3142145</ArticleId>
            <ArticleId IdType="pubmed">21799828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Post DMB, Slutter B, Schilling B, Chande AT, Rasmussen JA, Jones BD, D’Souza AK, Reinders LM, Harty JT, Gibson BW, Apicella MA. 
2017. 
Characterization of inner and outer membrane proteins from Francisella tularensis strains LVS and Schu S4 and identification of potential subunit vaccine candidates. mBio
8:e01592-17. doi:10.1128/mBio.01592-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01592-17</ArticleId>
            <ArticleId IdType="pmc">PMC5635693</ArticleId>
            <ArticleId IdType="pubmed">29018123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherwonogrodzky JW, Clark AG. 
1982. 
Production of the Kanagawa hemolysin by Vibrio parahaemolyticus in a synthetic medium. Infect Immun
37:60–63. doi:10.1128/IAI.37.1.60-63.1982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.37.1.60-63.1982</ArticleId>
            <ArticleId IdType="pmc">PMC347490</ArticleId>
            <ArticleId IdType="pubmed">7107010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Champion AE, Bandara AB, Mohapatra N, Fulton KM, Twine SM, Inzana TJ. 
2018. 
Further characterization of the capsule-like complex (CLC) produced by Francisella tularensis subspecies tularensis: protective efficacy and similarity to outer membrane vesicles. Front Cell Infect Microbiol
8:182. doi:10.3389/fcimb.2018.00182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2018.00182</ArticleId>
            <ArticleId IdType="pmc">PMC6013578</ArticleId>
            <ArticleId IdType="pubmed">29963499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV. 
2008. 
Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect Immun
76:3664–3671. doi:10.1128/IAI.00374-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00374-08</ArticleId>
            <ArticleId IdType="pmc">PMC2493219</ArticleId>
            <ArticleId IdType="pubmed">18505805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nano FE.
1988. 
Identification of a heat-modifiable protein of Francisella tularensis and molecular cloning of the encoding gene. Microb Pathog
5:109–119. doi:10.1016/0882-4010(88)90013-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0882-4010(88)90013-7</ArticleId>
            <ArticleId IdType="pubmed">3237052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW. 
2011. 
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine
29:6941–6947. doi:10.1016/j.vaccine.2011.07.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.07.075</ArticleId>
            <ArticleId IdType="pmc">PMC3428214</ArticleId>
            <ArticleId IdType="pubmed">21803089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCaig WD, Koller A, Thanassi DG. 
2013. 
Production of outer membrane vesicles and outer membrane tubes by Francisella novicida. J Bacteriol
195:1120–1132. doi:10.1128/JB.02007-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.02007-12</ArticleId>
            <ArticleId IdType="pmc">PMC3592013</ArticleId>
            <ArticleId IdType="pubmed">23264574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierson T, Matrakas D, Taylor YU, Manyam G, Morozov VN, Zhou W, van Hoek ML. 
2011. 
Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. J Proteome Res
10:954–967. doi:10.1021/pr1009756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/pr1009756</ArticleId>
            <ArticleId IdType="pubmed">21138299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas RM, Twine SM, Fulton KM, Tessier L, Kilmury SL, Ding W, Harmer N, Michell SL, Oyston PC, Titball RW, Prior JL. 
2011. 
Glycosylation of DsbA in Francisella tularensis subsp. tularensis. J Bacteriol
193:5498–5509. doi:10.1128/JB.00438-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00438-11</ArticleId>
            <ArticleId IdType="pmc">PMC3187430</ArticleId>
            <ArticleId IdType="pubmed">21803994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sara M, Sleytr UB. 
2000. 
S-Layer proteins. J Bacteriol
182:859–868. doi:10.1128/jb.182.4.859-868.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.182.4.859-868.2000</ArticleId>
            <ArticleId IdType="pmc">PMC94357</ArticleId>
            <ArticleId IdType="pubmed">10648507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sara M, Sleytr UB. 
1996. 
Crystalline bacterial cell surface layers (S-layers): from cell structure to biomimetics. Prog Biophys Mol Biol
65:83–111. doi:10.1016/s0079-6107(96)00007-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0079-6107(96)00007-7</ArticleId>
            <ArticleId IdType="pubmed">9029942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sleytr UB, Egelseer EM, Ilk N, Pum D, Schuster B. 
2007. 
S-Layers as a basic building block in a molecular construction kit. FEBS J
274:323–334. doi:10.1111/j.1742-4658.2006.05606.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-4658.2006.05606.x</ArticleId>
            <ArticleId IdType="pubmed">17181542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneitz C, Nuotio L, Lounatma K. 
1993. 
Adhesion of Lactobacillus acidophilus to avian intestinal epithelial cells mediated by the crystalline bacterial cell surface layer (S-layer). J Appl Bacteriol
74:290–294. doi:10.1111/j.1365-2672.1993.tb03028.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.1993.tb03028.x</ArticleId>
            <ArticleId IdType="pubmed">8468261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei Z, Ellison RT III, Lewis RV, Blaser MJ. 
1988. 
Purification and characterization of a family of high molecular weight surface-array proteins from Campylobacter fetus. J Biol Chem
263:6416–6420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3360785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messner P, Steiner K, Zarschler K, Schaffer C. 
2008. 
S-layer nanoglycobiology of bacteria. Carbohydr Res
343:1934–1951. doi:10.1016/j.carres.2007.12.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.carres.2007.12.025</ArticleId>
            <ArticleId IdType="pmc">PMC4381302</ArticleId>
            <ArticleId IdType="pubmed">18336801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freudenberger Catanzaro KC, Champion AE, Mohapatra N, Cecere T, Inzana TJ. 
2017. 
Glycosylation of a capsule-like complex (CLC) by Francisella novicida is required for virulence and partial protective immunity in mice. Front Microbiol
8:935. doi:10.3389/fmicb.2017.00935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2017.00935</ArticleId>
            <ArticleId IdType="pmc">PMC5447757</ArticleId>
            <ArticleId IdType="pubmed">28611741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sampath V, McCaig WD, Thanassi DG. 
2018. 
Amino acid deprivation and central carbon metabolism regulate the production of outer membrane vesicles and tubes by Francisella. Mol Microbiol
107:523–541. doi:10.1111/mmi.13897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.13897</ArticleId>
            <ArticleId IdType="pubmed">29240272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oyston PC.
2009. 
Francisella tularensis vaccines. Vaccine
27(Suppl 4):D48–D51. doi:10.1016/j.vaccine.2009.07.090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2009.07.090</ArticleId>
            <ArticleId IdType="pubmed">19837286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ray HJ, Chu P, Wu TH, Lyons CR, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP. 
2010. 
The Fischer 344 rat reflects human susceptibility to Francisella pulmonary challenge and provides a new platform for virulence and protection studies. PLoS One
5:e9952. doi:10.1371/journal.pone.0009952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0009952</ArticleId>
            <ArticleId IdType="pmc">PMC2848594</ArticleId>
            <ArticleId IdType="pubmed">20376351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holland KM, Rosa SJ, Kristjansdottir K, Wolfgeher D, Franz BJ, Zarrella TM, Kumar S, Sunagar R, Singh A, Bakshi CS, Namjoshi P, Barry EM, Sellati TJ, Kron SJ, Gosselin EJ, Reed DS, Hazlett K. 
2017. 
Differential growth of Francisella tularensis, which alters expression of virulence factors, dominant antigens, and surface-carbohydrate synthases, governs the apparent virulence of Ft SchuS4 to immunized animals. Front Microbiol
8:1158. doi:10.3389/fmicb.2017.01158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2017.01158</ArticleId>
            <ArticleId IdType="pmc">PMC5479911</ArticleId>
            <ArticleId IdType="pubmed">28690600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR. 
2007. 
Genome-wide identification of Francisella tularensis virulence determinants. Infect Immun
75:3089–3101. doi:10.1128/IAI.01865-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01865-06</ArticleId>
            <ArticleId IdType="pmc">PMC1932872</ArticleId>
            <ArticleId IdType="pubmed">17420240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su J, Asare R, Yang J, Nair MK, Mazurkiewicz JE, Abu-Kwaik Y, Zhang JR. 
2011. 
The capBCA locus is required for intracellular growth of Francisella tularensis LVS. Front Microbiol
2:83. doi:10.3389/fmicb.2011.00083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2011.00083</ArticleId>
            <ArticleId IdType="pmc">PMC3128946</ArticleId>
            <ArticleId IdType="pubmed">21747799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Champion AE, Catanzaro KCF, Bandara AB, Inzana TJ. 
2019. 
Formation of the Francisella tularensis biofilm is affected by cell surface glycosylation, growth medium, and a glucan exopolysaccharide. Sci Rep
9:12252. doi:10.1038/s41598-019-48697-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-48697-x</ArticleId>
            <ArticleId IdType="pmc">PMC6706388</ArticleId>
            <ArticleId IdType="pubmed">31439876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colquhoun DJ, Larsson P, Duodu S, Forsman M. 
2014. 
The family Francisellaceae, p 287–314. In
Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (ed), The prokaryotes. Springer, Berlin, Germany.</Citation>
        </Reference>
        <Reference>
          <Citation>Gunn JS, Ernst RK. 
2007. 
The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci
1105:202–218. doi:10.1196/annals.1409.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1409.006</ArticleId>
            <ArticleId IdType="pmc">PMC2742961</ArticleId>
            <ArticleId IdType="pubmed">17395723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raynaud C, Meibom KL, Lety MA, Dubail I, Candela T, Frapy E, Charbit A. 
2007. 
Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun
75:536–541. doi:10.1128/IAI.01429-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01429-06</ArticleId>
            <ArticleId IdType="pmc">PMC1828372</ArticleId>
            <ArticleId IdType="pubmed">17030571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas RM, Titball RW, Oyston PC, Griffin K, Waters E, Hitchen PG, Michell SL, Grice ID, Wilson JC, Prior JL. 
2007. 
The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun
75:371–378. doi:10.1128/IAI.01241-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01241-06</ArticleId>
            <ArticleId IdType="pmc">PMC1828428</ArticleId>
            <ArticleId IdType="pubmed">17074846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradov E, Conlan WJ, Gunn JS, Perry MB. 
2004. 
Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr Res
339:649–654. doi:10.1016/j.carres.2003.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.carres.2003.12.013</ArticleId>
            <ArticleId IdType="pubmed">15013402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johansson A, Celli J, Conlan W, Elkins KL, Forsman M, Keim PS, Larsson P, Manoil C, Nano FE, Petersen JM, Sjostedt A. 
2010. 
Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int J Syst Evol Microbiol
60:1717–1718. (Reply, 1718–1720.) doi:10.1099/ijs.0.022830-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/ijs.0.022830-0</ArticleId>
            <ArticleId IdType="pmc">PMC7442299</ArticleId>
            <ArticleId IdType="pubmed">20688748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kieffer TL, Cowley S, Nano FE, Elkins KL. 
2003. 
Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect
5:397–403. doi:10.1016/S1286-4579(03)00052-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1286-4579(03)00052-2</ArticleId>
            <ArticleId IdType="pubmed">12737995</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
